<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <link rel="shortcut icon" href="../images/favicon.png" type="image/x-icon">
  <title>Infective Endocarditis</title>
  <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet">
  <link rel="stylesheet" href="../style.css">
  <link rel="stylesheet" href="../notes.css">

</head>
<body>
  <input type="checkbox" id="main-navigation-toggle" class="btn btn--close" title="Toggle main navigation" />
  <label for="main-navigation-toggle">
    <span></span>
  </label>
  
  <a href="../index.html">
   <div class="home-navigation">
      mtr<span class="logo-dot">.</span>
    </div>
  </a>


    <nav id="main-navigation" class="nav-main">
    <ul class="menu">
      <li class="menu__item">
        <a class="menu__link" href="../index.html">Home</a>
      </li>

      <li class="menu__item">
        <a class="menu__link" href="../about-temp2.html">About</a>
      </li>
    </ul>
  </nav>
  
      <!-- Toggle switch for dark mode -->
      <div class="dark-mode-toggle">
        <label class="switch-toggle">
            <input type="checkbox" id="dark-mode-toggle-checkbox">
            <span class="toggle-slider"></span>
        </label>
      </div>

      <!-- Progress Bar  -->
      <div id="progress-container">
        <div id="progress-bar"></div>
    </div>
      
<!-- SIDEBAR -->
<div id="sidebar" class="sidebar">
  <button id="closeSidebarBtn" class="btn toggle-btn close-btn">Close</button>
  <ul class="sidebar-menu toggle-menu">
    <!-- Add the list of topics dynamically using JavaScript -->
  </ul>
</div>

<!-- Toggle button to open the sidebar -->
<button id="toggleSidebarBtn" class="btn toggle-btn">&#9776;</button>

<!-- END OF SIDEBAR -->

  <main class="page-container">
    <div class="contribute-cta">
      <p>Help make this betterüíú</p>
      <span><a href="../contribute.html">Contribute here</a> </span>
    </div>


  <!-- TOPIC AND IMAGE CONTAINER  -->

  <h1>Infective Endocarditis</h1>


  <!-- END OF TOPIC AND IMAGE CONTAINER  -->
  


    <article class="notes">
        <a id='top'></a>
    <article>

          <!-- LEARNING OBJECTIVES CONTAINER  -->
              <div class="custom-card" id="custom-card-1">
                <div class="icon"><img src="../images/icons/light-bulb.png" alt="Icon" class="icon"></div>
                <div class="title"> 
                  <h2>What You Will Learn</h2>
                </div>
                <div class="line">
                  <p>After reading this note, you should be able to...</p>
                </div>
                <div class="content">
                  <ul>
                    <li><i>This content is not available yet.</i></li>
                </ul>
                </div>
                <div class="read-more" onclick="toggleContent('custom-card-1')">Read More üç™</div>
              </div>
            
          <!-- END OF LEARNING OBJECTIVES CONTAINER  -->
        
        
          <!-- SHOW AND HIDE OUTLINE CONTAINER  -->
            <div class="outline2">
        
              <input type="radio" name="control-2" id="show-2">
              <label for="show-2">üêµ&nbsp; &nbsp;Show Outline</label>
              <input type="radio" name="control-2" id="hide-2">
              <label for="hide-2">üôà&nbsp; &nbsp; Hide Outline</label>
              <div class="contents">
                <div class="icon-box">
                  <!-- Replace 'path/to/your/icon.png' with the actual path to your PNG icon -->
                  <img src="../images/icons/book.png" alt="Icon" class="icon">
                </div>
                <div id="tableOfContents">
                    <ol id="tocList"></ol>
                </div>
              </div>
             <div>
        
        <!-- END OF SHOW AND HIDE OUTLINE CONTAINER  -->
        
        
          <br>
        
            <!-- BEGINNING OF NOTE -->
        
      <section id='header-1'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-1'>Definition</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Infective endocarditis</strong> refers to microbial infection of the endocardial surface (<strong>endocardium</strong>) of the heart.</li>
              <li>Considerable cause of <strong>morbidity</strong> and <strong>mortality</strong> in children with underlying <strong>heart disease</strong>.</li>
              <li>Is one of the most dreaded complications of <strong>structural heart disease</strong>.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-2'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-2'>Epidemiology</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>The estimated incidence in children was <strong>0.3 per 100,000 children</strong> per year with a <strong>mortality of 11.6%</strong>.</li>
              <li>There has been an increase in the incidence in the developed world of recent years resulting from:
                <ul>
                  <li><strong>Increased survival</strong> of patients with cardiovascular disease,</li>
                  <li><strong>Advances in surgical and medical approaches</strong> to congenital heart disease (CHD) during the past several decades,</li>
                  <li><strong>Aggressive treatment regimens</strong> in neonatal and pediatric intensive care units.</li>
                </ul>
              </li>
              <li>Whereas <strong>rheumatic heart disease</strong> was a major underlying cardiac condition in U.S. children with endocarditis until the 1970s, it has become an unusual underlying cardiac condition in more recent years. This is not true in developing countries, where endocarditis remains an important complicating factor in individuals with rheumatic heart disease.</li>
              <li>CHD most associated with infective endocarditis include:
                <ul>
                  <li><strong>Tetralogy of Fallot</strong>,</li>
                  <li><strong>Ventricular septal defect</strong>,</li>
                  <li><strong>Patent ductus arteriosus</strong>,</li>
                  <li><strong>Aortic valve abnormalities</strong>.</li>
                </ul>
              </li>
              <li>Previous corrective or palliative surgery for CHD, with or without implanted vascular grafts, patches, or prosthetic cardiac valves, and various reports have indicated that <strong>50% to 70%</strong> of children with CHD have had previous cardiac surgery.</li>
              <li><strong>Neonates:</strong> Most cases occur in structurally normal hearts. It is relatively uncommon.</li>
              <li>Patients with underlying cardiovascular disease may develop endocarditis at any age in childhood, adolescence, or adulthood.</li>
            </ul>
            

        </div>
      </section>

      <section id='header-3'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-3'>Classification</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Acute</strong> vs <strong>subacute</strong></li>
              <li><strong>Native valve</strong> vs <strong>prosthetic valve</strong></li>
              <li>Based on <strong>organism</strong>:
                <ul>
                  <li><strong>Viral</strong></li>
                  <li><strong>Bacterial</strong></li>
                  <li><strong>Fungal</strong></li>
                </ul>
              </li>
            </ul>
            
        </div>
      </section>

      <section id='header-4'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-4'>Aetiology</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>A wide variety of organisms are associated with infective endocarditis, but most commonly:
                <ul>
                  <li><strong>Viridans streptococci</strong> (S. mutans, S. mitis, S. sanguis)</li>
                  <li><strong>Staphylococcus aureus</strong></li>
                  <li><strong>Group D Streptococci</strong> (Enterococcus)</li>
                </ul>
              </li>
              <li>These are responsible for <strong>60%</strong> of cases of IE.</li>
              <li>Other organisms (Native valve):
                <ul>
                  <li><strong>Coagulase negative staphylococci</strong></li>
                  <li><strong>Other streptococci</strong></li>
                  <li><strong>HACEK</strong></li>
                  <li><strong>Pseudomonas</strong></li>
                  <li><strong>Coxiella burnetii</strong></li>
                  <li><strong>Brucella</strong></li>
                  <li><strong>Chlamydia spp</strong></li>
                  <li><strong>Neisseria gonorrheae</strong></li>
                  <li><strong>Legionella</strong></li>
                  <li><strong>Bartonella</strong></li>
                  <li><strong>Campylobacter</strong></li>
                  <li><strong>Pasteurella multocida</strong></li>
                </ul>
              </li>
              <li>Prosthetic valve:
                <ul>
                  <li><strong>Staphylococcus epidermidis</strong></li>
                  <li><strong>Staphylococcus aureus</strong></li>
                  <li><strong>Viridans group streptococcus</strong></li>
                  <li><strong>Pseudomonas aeruginosa</strong></li>
                  <li><strong>Serratia marcescens</strong></li>
                  <li><strong>Diphtheroids</strong></li>
                  <li><strong>Legionella species</strong></li>
                  <li><strong>HACEK group</strong></li>
                  <li><strong>Fungi</strong> (Candida, Aspergillus, Torulopsis glabrata)</li>
                </ul>
              </li>
            </ul>
            
        </div>
      </section>

      <section id='header-5'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-5'>Pathogenesis</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Risk factors</strong>:
                <ul>
                  <li><strong>Underlying congenital heart disease</strong></li>
                  <li><strong>Rheumatic heart disease</strong></li>
                  <li><strong>Valvular abnormalities</strong></li>
                  <li><strong>Prosthetic valves</strong></li>
                  <li><strong>Intravenous drug abusers</strong></li>
                  <li><strong>Indwelling devices</strong></li>
                  <li><strong>Immunosuppression</strong></li>
                  <li><strong>Dental / gastrointestinal / urinary procedures</strong></li>
                  <li><strong>Poor oral hygiene</strong></li>
                </ul>
              </li>
              <li><strong>Two fundamental requirements</strong>:
                <ul>
                  <li><strong>Bacteremia</strong></li>
                  <li><strong>Endocardial damage/injury</strong></li>
                </ul>
              </li>
              <li>The presence of <strong>structural abnormalities</strong> of the heart or great arteries, with a significant <strong>pressure gradient</strong> or <strong>turbulence</strong>, produces endothelial damage.</li>
              <li>Such endothelial damage induces <strong>thrombus formation</strong> with deposition of sterile clumps of <strong>platelet</strong> and <strong>fibrin</strong> (<strong>nonbacterial thrombotic endocarditis</strong>), which provides a nidus for bacteria to adhere and eventually form an infected vegetation.</li>
              <li><strong>Platelets</strong> and <strong>fibrin</strong> are deposited over the organisms, leading to enlargement of the vegetation.</li>
            </ul>
            

            <h4>Nonbacterial Thrombotic Endocarditis</h4>
            <ul>
              <li><strong>Endothelial injury</strong></li>
              <li><strong>Hypercoagulable state</strong></li>
              <li><strong>Platelet-fibrin thrombi</strong></li>
              <li>Lesions seen at <strong>coaptation points</strong> of valves:
                <ul>
                  <li><strong>Atrial surface</strong> mitral/tricuspid</li>
                  <li><strong>Ventricular surface</strong> aortic/pulmonic</li>
                </ul>
              </li>
              <li><strong>Modes of endothelial injury</strong>:
                <ul>
                  <li><strong>High velocity jet</strong></li>
                  <li><strong>Flow from high pressure to low pressure chamber</strong></li>
                  <li><strong>Flow across narrow orifice of high velocity</strong></li>
                </ul>
              </li>
              <li><strong>Bacteria</strong> deposited on edges of <strong>low pressure sink</strong> or site of <strong>jet impaction</strong></li>
            </ul>
            
            <h4>Conversion of NBTE to IE</h4>
            <ul>
              <li><strong>Frequency & magnitude of bacteremia</strong></li>
              <li><strong>Density of colonizing bacteria</strong>:
                <ul>
                  <li><strong>Oral</strong> > <strong>GU</strong> > <strong>GI</strong></li>
                </ul>
              </li>
              <li><strong>Disease state of surface</strong>:
                <ul>
                  <li><strong>Infected surface</strong> > <strong>colonized surface</strong></li>
                </ul>
              </li>
              <li><strong>Extent of trauma</strong></li>
              <li><strong>Resistance of organism to host defenses</strong></li>
              <li>Most <strong>aerobic gram negatives</strong> susceptible to <strong>complement-mediated bactericidal effect</strong> of serum</li>
              <li><strong>Tendency to adhere to endothelium</strong>:
                <ul>
                  <li><strong>Dextran producing strep</strong></li>
                  <li><strong>Fibronectin receptors</strong> on staph, enterococcus, strep, Candida</li>
                </ul>
              </li>
            </ul>
            
        </div>
      </section>

      <section id='header-6'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-6'>Pathophysiology</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Clinical manifestations</strong>:
                <ul>
                  <li><strong>Direct</strong>:
                    <ul>
                      <li>Constitutional symptoms of infection (<strong>cytokine</strong>)</li>
                    </ul>
                  </li>
                  <li><strong>Indirect</strong>:
                    <ul>
                      <li><strong>Local destructive effects of infection</strong></li>
                      <li><strong>Embolization</strong> ‚Äì septic or bland</li>
                      <li><strong>Hematogenous seeding of infection</strong>:
                        <ul>
                          <li>N.B. may present as local infection or persistent fever; metastatic abscesses may be small, <strong>miliary</strong></li>
                        </ul>
                      </li>
                      <li><strong>Immune response</strong>:
                        <ul>
                          <li><strong>Immune complex</strong> or <strong>complement-mediated</strong></li>
                        </ul>
                      </li>
                    </ul>
                  </li>
                </ul>
              </li>
              <li><strong>Local destructive effects</strong>:
                <ul>
                  <li><strong>Valvular distortion/destruction</strong></li>
                  <li><strong>Chordal rupture</strong></li>
                  <li><strong>Perforation/fistula formation</strong></li>
                  <li><strong>Paravalvular abscess</strong></li>
                  <li><strong>Conduction abnormalities</strong></li>
                  <li><strong>Purulent pericarditis</strong></li>
                  <li><strong>Functional valve obstruction</strong></li>
                </ul>
              </li>
              <li>The immediate consequences of endocarditis include:
                <ul>
                  <li><strong>Vegetation formation</strong></li>
                  <li><strong>Hemodynamic alterations</strong></li>
                  <li>The <strong>clinical syndrome</strong></li>
                </ul>
              </li>
              <li>Many important <strong>extracardiac manifestations</strong> in endocarditis are related to <strong>immunologic mechanisms</strong>.</li>
              <li><strong>Rheumatoid factor</strong> is present for 6 weeks or longer in sera of about half of the patients with endocarditis. This is considered to be due to a gradual hyperimmunization of the host.</li>
              <li>Another immunologic sequela of endocarditis is the presence of <strong>circulating immune complexes</strong> in the sera of patients.</li>
              <li>The <strong>kidney</strong> is an extracardiac site frequently affected in patients with endocarditis. Microscopic and macroscopic emboli are the most frequently described noncardiac pathologic lesions.</li>
              <li>However, <strong>abscess formation</strong> has also been reported following septic embolization to the kidney.</li>
              <li>The nephritis seen in patients with endocarditis may manifest itself microscopically as either <strong>focal</strong> or <strong>diffuse glomerulonephritis</strong>.</li>
            </ul>
            
        </div>
      </section>

      <section id='header-7'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-7'>Clinical Features </a>
          </h2>
        </header>
        <div class='body'>
            <h4>History</h4>
            <ul>
              <li>Most patients have a history of an <strong>underlying heart defect</strong>.</li>
              <li>However, some patients with <strong>bicuspid aortic valve</strong> may not have been diagnosed with the defect before the onset of the endocarditis.</li>
              <li>A history of a recent <strong>dental procedure</strong> or <strong>tonsillectomy</strong> is occasionally present, but a history of <strong>toothache</strong> (from dental or gingival disease) is more frequent than a history of a procedure.</li>
              <li><strong>Endocarditis</strong> is rare in infancy; at this age, it usually follows <strong>open-heart surgery</strong>.</li>
              <li>The onset is usually <strong>insidious</strong> with prolonged <strong>low-grade fever</strong> and somatic complaints, including:
                <ul>
                  <li><strong>Fatigue</strong></li>
                  <li><strong>Weakness</strong></li>
                  <li><strong>Loss of appetite</strong></li>
                  <li><strong>Pallor</strong></li>
                  <li><strong>Arthralgia</strong></li>
                  <li><strong>Myalgias</strong></li>
                  <li><strong>Weight loss</strong></li>
                  <li><strong>Diaphoresis</strong></li>
                </ul>
              </li>
            </ul>
            
            <h4>Physical Examination</h4>
            <ul>
              <li><strong>Heart murmur</strong> is universal (<strong>100%</strong>):
                <ul>
                  <li>The appearance of a <strong>new heart murmur</strong> and an increase in the intensity of an existing murmur are important.</li>
                </ul>
              </li>
              <li><strong>Fever</strong> is common (<strong>80% to 90%</strong>). The temperature fluctuates between <strong>38.3¬∞C</strong> and <strong>39.4¬∞C</strong>.</li>
              <li><strong>Splenomegaly</strong> is common (<strong>70%</strong>).</li>
              <li><strong>Skin manifestations</strong> (<strong>50%</strong>) (either secondary to microembolization or as an immunologic phenomenon) may be present in the following forms:
                <ul>
                  <li><strong>Petechiae</strong> on the skin, mucous membranes, or conjunctivae are the most frequent skin lesions.</li>
                  <li><strong>Osler's nodes</strong> (tender, pea-sized red nodes at the ends of the fingers or toes) are rare in children.</li>
                  <li><strong>Janeway's lesions</strong> (small, painless, hemorrhagic areas on the palms or soles) are rare.</li>
                  <li><strong>Splinter hemorrhages</strong> (linear hemorrhagic streaks beneath the nails) are also rare.</li>
                </ul>
              </li>
            </ul>
            
            <h4>Clinical Features</h4>
            <ul>
              <li><strong>Embolic</strong> or <strong>immunologic phenomena</strong> in other organs are present in <strong>50%</strong> of cases:
                <ul>
                  <li><strong>Pulmonary emboli</strong> may occur in patients with <strong>VSD</strong>, <strong>PDA</strong>, or a <strong>systemic-to-PA shunt</strong>.</li>
                  <li><strong>Seizures</strong> and <strong>hemiparesis</strong> are the result of embolization to the central nervous system (<strong>20%</strong>) and are more common with <strong>left-sided defects</strong> such as aortic and mitral valve disease or with <strong>cyanotic heart disease</strong>.</li>
                  <li><strong>Haematuria</strong> and <strong>renal failure</strong> may occur.</li>
                  <li><strong>Roth's spots</strong> (oval, retinal hemorrhages with pale centers located near the optic disc) occur in less than <strong>5%</strong> of patients.</li>
                </ul>
              </li>
            </ul>
            
            <!-- image here -->
            <div class="image-container">
                <img src="../figures/infective-endocarditis (1).jpg" alt="" onclick="openModal(this)">
                <div class="caption">Janeway Lesions</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Janeway Lesions</div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/infective-endocarditis (2).jpg" alt="" onclick="openModal(this)">
                <div class="caption">Janeway Lesions</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Janeway Lesions</div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/infective-endocarditis (3).jpg" alt="" onclick="openModal(this)">
                <div class="caption">Splinter Hemorrhage</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Splinter Hemorrhage</div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/infective-endocarditis (4).jpg" alt="" onclick="openModal(this)">
                <div class="caption">Osler‚Äôs Nodes</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Osler‚Äôs Nodes</div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/infective-endocarditis (5).jpg" alt="" onclick="openModal(this)">
                <div class="caption">Subconjunctival Hemorrhages</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Subconjunctival Hemorrhages</div>
              </div>

                          <!-- image here -->
            <div class="image-container">
                <img src="../figures/infective-endocarditis (6).jpg" alt="" onclick="openModal(this)">
                <div class="caption">Roth‚Äôs Spots</div>
              </div>
              
              <div id="myModal" class="modal">
                <span class="close" onclick="closeModal()">&times;</span>
                <img class="modal-content" id="modalImage">
                <div id="caption" class="caption">Roth‚Äôs Spots</div>
              </div>


              <h4>Clinical Features</h4>
              <ul>
                <li><strong>Carious teeth</strong> or <strong>periodontal</strong> or <strong>gingival disease</strong> is frequently present.</li>
                <li><strong>Clubbing of fingers</strong> in the absence of cyanosis develops rarely in more chronic cases.</li>
                <li>Signs of <strong>heart failure</strong> may be present as a complication of the infection.</li>
              </ul>
              
              <h4>IE in Neonates</h4>
              <ul>
                <li>The <strong>clinical manifestations</strong> in a neonate with IE are nonspecific (such as <strong>respiratory distress</strong>, <strong>tachycardia</strong>) and may be indistinguishable from <strong>septicemia</strong> or <strong>congestive heart failure (CHF)</strong> from other causes.</li>
                <li><strong>Embolic phenomena</strong> (such as <strong>osteomyelitis</strong>, <strong>meningitis</strong>, <strong>pneumonia</strong>) are common.</li>
                <li>There may be <strong>neurologic signs and symptoms</strong> (such as <strong>seizures</strong>, <strong>hemiparesis</strong>, <strong>apnea</strong>).</li>
              </ul>
              
        </div>
      </section>

      <section id='header-8'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-8'> Investigations</a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Blood culture</strong>: Positive in <strong>90%</strong> of cases without antibiotic use and <strong>50-60%</strong> with antibiotic use.
                <ul>
                  <li>Maximise yield by:
                    <ul>
                      <li>Taking <strong>three cultures</strong> within the first <strong>24 hours</strong></li>
                      <li>Taking cultures at the same or <strong>different site</strong></li>
                      <li>If negative in <strong>48 hours</strong>, take another two</li>
                      <li>Cultures should be taken <strong>before commencement of antibiotics</strong>, if possible</li>
                      <li>Taking <strong>1-3ml</strong> in young children and <strong>5-7ml</strong> in older children</li>
                      <li><strong>Aerobic cultures</strong> should be performed, taking note of requirements for <strong>fastidious organisms</strong></li>
                    </ul>
                  </li>
                </ul>
              </li>
              <li><strong>Echocardiography</strong>:
                <ul>
                  <li><strong>TTE</strong> has become an extremely valuable tool in the evaluation for IE. <strong>TEE</strong> may be more sensitive.</li>
                  <li><strong>Suggestive findings</strong> include:
                    <ul>
                      <li><strong>Vegetations</strong></li>
                      <li><strong>Valvular dysfunction</strong></li>
                      <li><strong>Perivalvular extension</strong> including <strong>abscesses</strong></li>
                      <li><strong>Underlying heart disease</strong></li>
                    </ul>
                  </li>
                </ul>
              </li>
              <li><strong>Other investigations</strong>:
                <ul>
                  <li><strong>Full blood count</strong>:
                    <ul>
                      <li><strong>Hb</strong> < <strong>12g/dl</strong></li>
                      <li><strong>Leucocytosis</strong> with a <strong>left shift</strong></li>
                      <li><strong>Platelets</strong> may be low or normal</li>
                    </ul>
                  </li>
                  <li><strong>Raised acute phase reactants</strong></li>
                  <li><strong>Urinalysis</strong>: <strong>Microscopic haematuria</strong></li>
                </ul>
              </li>
            </ul>
            
            <section id='heading-8-1'>
                <header>
                  <h3>
                    <a aria-hidden href='#heading-8-1'>Modified Duke‚Äôs Criteria</a>
                  </h3>
                </header>
                <div class='body'>
                    <ul>
                      <li><strong>Definite IE</strong></li>
                      <li><strong>Possible IE</strong></li>
                      <li><strong>Rejected IE</strong></li>
                    </ul>
                    
                    <h4>Definite IE</h4>
                    <ul>
                      <li><strong>Pathologic criteria</strong>:
                        <ul>
                          <li><strong>Micro-organisms</strong> demonstrated by culture or histologic examination of a vegetation</li>
                          <li><strong>Pathological lesions</strong>: vegetation or intracardiac abscess confirmed by histologic examination showing active endocarditis</li>
                        </ul>
                      </li>
                    </ul>
                    
                    <h4>Major Criteria</h4>
                    <ol>
                      <li><strong>Blood culture positive for infective endocarditis (IE)</strong>:
                        <ul>
                          <li><strong>Typical micro-organisms</strong> consistent with IE from 2 separate blood cultures</li>
                          <li><strong>Micro-organisms</strong> consistent with IE from persistently positive blood cultures defined as follows:
                            <ul>
                              <li>At least <strong>2 positive cultures</strong> of blood samples drawn >12 h apart; or</li>
                              <li>All of <strong>3 or a majority of 4 separate cultures</strong> of blood (with first and last sample drawn 1 h apart)</li>
                            </ul>
                          </li>
                          <li><strong>Single positive blood culture</strong> for <strong>Coxiella burnetii</strong></li>
                        </ul>
                      </li>
                      <li><strong>Evidence of endocardial involvement</strong>:
                        <ul>
                          <li><strong>Echocardiogram positive for IE</strong> defined as follows:</li>
                          <li><strong>New valvular regurgitation</strong> (worsening or changing or pre-existing murmur not sufficient)</li>
                        </ul>
                      </li>
                    </ol>
                    
                    <h4>Minor Criteria</h4>
                    <ol>
                      <li><strong>Predisposition</strong>, predisposing heart condition, or injection drug use</li>
                      <li><strong>Fever</strong>, temperature >38¬∞C</li>
                      <li><strong>Vascular phenomena</strong></li>
                      <li><strong>Immunologic phenomena</strong>: glomerulonephritis, Osler nodes, Roth spots, and rheumatoid factor</li>
                      <li><strong>Microbiologic evidence</strong>: positive blood culture, but does not meet a major criterion as noted above</li>
                    </ol>
                    
                    <h4>Diagnosis</h4>
                    <ul>
                      <li><strong>Definite IE</:
                        <ul>
                          <li><strong>2 major</strong> OR</li>
                          <li><strong>1 major + 3 minor</strong> OR</li>
                          <li><strong>5 minor</strong></li>
                        </ul>
                      </li>
                      <li><strong>Possible IE</strong>:
                        <ul>
                          <li><strong>1 major + 1 minor</strong> OR</li>
                          <li><strong>3 minor</strong></li>
                        </ul>
                      </li>
                    </ul>
                    
    
                </div>
              </section>
        </div>
      </section>

      <section id='header-9'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-9'>Treatment </a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li><strong>Antibiotics</strong> should be started as soon as possible.</li>
              <li><strong>Bactericidal antibiotics</strong> should be used.</li>
              <li>They should be given <strong>parenterally for 4-6 weeks</strong>.</li>
              <li>Antibiotics must include a <strong>beta-lactamase resistant antibiotic</strong> + <strong>aminoglycoside</strong>.</li>
            </ul>
            
            <ul>
              <li><strong>Antistaphylococcal antibiotics</strong> (e.g., nafcillin, oxacillin, co-amoxiclav, vancomycin) +</li>
              <li><strong>Aminoglycoside</strong> (gentamicin or amikacin for the first 1 week)</li>
              <li><strong>Alternative therapy</strong>: Ceftriaxone + gentamicin</li>
            </ul>
            
            <ul>
              <li>When cultures are received, <strong>appropriate antibiotics</strong> should be used.</li>
              <li><strong>Viridans streptococci</strong>: Penicillin + gentamicin</li>
              <li><strong>Staphylococcus aureus</strong>: co-amoxiclav or ampicillin/sulbactam or vancomycin + gentamicin</li>
              <li><strong>HACEK</strong>: Ampicillin/sulbactam or ceftriaxone + gentamicin</li>
            </ul>
            
            <ul>
              <li><strong>Others</strong>:
                <ul>
                  <li><strong>Fungal</strong>: Amphotericin B</li>
                  <li><strong>Manage heart failure</strong></li>
                  <li><strong>Surgery</strong>: drain abscesses, valve replacement, etc.</li>
                </ul>
              </li>
            </ul>
            
        </div>
      </section>

      <section id='header-10'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-10'> Prevention</a>
          </h2>
        </header>
        <div class='body'>

            <h4>Prophylactic Regimen Targeted Against Likely Organism</h4>
            <ul>
              <li><strong>Streptococcus viridans</strong> ‚Äì oral, respiratory, esophageal</li>
              <li><strong>Enterococcus</strong> ‚Äì genitourinary, gastrointestinal</li>
              <li><strong>Staphylococcus aureus</strong> ‚Äì infected skin, mucosal surfaces</li>
            </ul>
            
            <h4>Prevention ‚Äì The Procedure</h4>
            <ul>
              <li><strong>Dental procedures</strong> known to produce bleeding</li>
              <li><strong>Tonsillectomy</strong></li>
              <li><strong>Surgery involving GI, respiratory mucosa</strong></li>
              <li><strong>Insertion of nasogastric tubes</strong></li>
              <li><strong>Gallbladder surgery</strong></li>
              <li><strong>Urethral catheterization</strong>, if infection present</li>
              <li><strong>Incision and drainage (I&D)</strong></li>
            </ul>
            
            <h4>Prevention ‚Äì The Underlying Lesion</h4>
            <ul>
              <li><strong>High Risk Lesions</strong>:
                <ul>
                  <li><strong>Prosthetic valves</strong></li>
                  <li><strong>Prior infective endocarditis (IE)</strong></li>
                  <li><strong>Cyanotic congenital heart disease</strong></li>
                  <li><strong>Patent ductus arteriosus (PDA)</strong></li>
                  <li><strong>Aortic regurgitation (AR), aortic stenosis (AS), mitral regurgitation (MR), mitral stenosis (MS) with MR</strong></li>
                  <li><strong>Ventricular septal defect (VSD)</strong></li>
                  <li><strong>Coarctation</strong></li>
                  <li><strong>Surgical systemic-pulmonary shunts</strong></li>
                </ul>
              </li>
              <li><strong>Intermediate Risk</strong>:
                <ul>
                  <li><strong>Mitral valve prolapse (MVP) with murmur</strong></li>
                  <li><strong>Pure mitral stenosis (MS)</strong></li>
                  <li><strong>Tricuspid disease</strong></li>
                  <li><strong>Pulmonary stenosis</strong></li>
                  <li><strong>Atrial septal hypertrophy (ASH)</strong></li>
                  <li><strong>Bicuspid aortic valve with no hemodynamic significance</strong></li>
                </ul>
              </li>
              <li><strong>Low/No Risk</strong>:
                <ul>
                  <li><strong>Mitral valve prolapse (MVP) without murmur</strong></li>
                  <li><strong>Trivial valvular regurgitation</strong></li>
                  <li><strong>Isolated atrial septal defect (ASD)</strong></li>
                  <li><strong>Implanted device</strong> (pacer, ICD)</li>
                  <li><strong>Coronary artery disease (CAD)</strong></li>
                  <li><strong>Coronary artery bypass grafting (CABG)</strong></li>
                </ul>
              </li>
            </ul>
            
            <h4>Prevention ‚Äì Antibiotic Prophylaxis</h4>
            <ul>
              <li>For most patients, <strong>oral amoxicillin 50 mg/kg</strong> 1 hour before the procedure</li>
              <li><strong>High-risk patients</strong>:
                <ul>
                  <li><strong>IM or IV ampicillin 50 mg/kg</strong> 30 minutes before the procedure or</li>
                  <li><strong>IM or IV gentamicin 1.5 mg/kg</strong> (maximum dose, 120 mg) given within 30 minutes before the procedure plus 6 hours later</li>
                </ul>
              </li>
              <li><strong>Ampicillin- and amoxicillin-allergic patients</strong>: Oral clindamycin 20 mg/kg 1 hour before the procedure</li>
            </ul>
            
        </div>
      </section>

      <section id='header-11'>
        <header>
          <h2>
            <a aria-hidden='true' href='#header-11'>Prognosis </a>
          </h2>
        </header>
        <div class='body'>
            <ul>
              <li>The overall recovery rate is <strong>80% to 85%</strong>.</li>
              <li>It is <strong>90% or better</strong> for <strong>Streptococcus viridans</strong> and <strong>enterococci</strong> and about <strong>50%</strong> for <strong>Staphylococcus organisms</strong>.</li>
              <li><strong>Fungal endocarditis</strong> is associated with a very poor outcome.</li>
            </ul>
            
        </div>
      </section>






      <hr style="margin: 3rem 0;">

      <!-- PRACTICE QUESTIONS CONTAINER -->

      <div class="custom-card" id="custom-card-2">
        <div class="icon"><img src="../images/icons/practice-questions.png" alt="Icon" class="icon"></div>
        <div class="title"> 
          <h2>Practice Questions</h2>
        </div>
        <div class="line">
          <p>Check how well you grasp the concepts by answering the following questions...</p>
        </div>
        <div class="content">
          <ol>
            <li><i>This content is not available yet.</i></li>
          </ol>
        </div>
        <div class="read-more" onclick="toggleContent('custom-card-2')">Read More üç™</div>
      </div>

      <!-- END OF PRACTICE QUESTIONS CONTAINER -->


      <!-- CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
      <div class="contact">
        <div class="comment-container">
          <div class="comment-icon">
            <!-- Add your icon image here -->
            <img src="../images/icons/comment.png" alt="Comment Icon">
          </div>
          <div class="comment-text">
            <!-- Add your text here -->
            <p>Send your comments, corrections, explanations/clarifications and requests/suggestions </p>
          </div>
          <a href="https://docs.google.com/forms/d/e/1FAIpQLSdx2teDCmW6ivSeKLQg7zF_jy7Yfg_1Gqm84_UT0PQPATsNug/viewform?usp=sf_link" class="comment-button">
            here
            <!-- <img src="../images/icons/whatsapp.png" alt="Image Icon"> -->
          </a>
        </div>

        <div class="contributors-container">

          <h2 class="contributors-header">Contributors</h2>
  
        <br>
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/woman.png" alt="Contributor 1 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">Jane Smith</h3>
                    <p class="contributor-description">She is not a real contributor.</p>
                    <div class="social-links">
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                        </a>
                        <a href="#" target="_blank" class="social-icon">
                            <img src="../images/icons/twitter.png" alt="Social Icon 2">
                        </a>
                    </div>
                </div>
            </div>
        
            <div class="contributor-box">
                <img class="contributor-avatar" src="../images/icons/man.png" alt="Contributor 2 Avatar">
                <div class="contributor-info">
                    <h3 class="contributor-name">John Doe</h3>
                    <p class="contributor-description">He is not a real contributor.</p>
                    <div class="social-links">
                      <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/whatsapp.png" alt="Social Icon 1">
                    </a>
                    <a href="#" target="_blank" class="social-icon">
                        <img src="../images/icons/linkedin.png" alt="Social Icon 2">
                    </a>
                    </div>
                </div>
            </div>
        
        </div>
      </div>

            <!-- END OF CONTACT- COMMENT AND CONTRIBUTORS CONTAINER -->
    </article>
   </article>
   <div style="height: 300px;"></div>
  </main>

  <footer>
    <div class="footer-container">
        <div>
          <p id="popup-trigger">disclaimer</p>

          <!-- The pop-up dive content -->
          <div id="popup" class="popup">
            <p>The contents on this ‚Äòwebsite‚Äô are for educational purposes only. The creators and operators of this website make no warranties, express or implied, regarding the accuracy, currency, or completeness of the information provided on the website. They shall not be held responsible for any errors or omissions, or for any actions taken based on the information provided on this website.</p>
            <button class="popup-close" onclick="closePopup()">Close</button>
          </div>    
          <p><a href="../about-temp2.html">about</a> </p>   
          <p><a href="../contribute.html">contribute</a> </p>
        </div>

        <div class="footer-beta">
          <p>thisisatestversion</p>
        </div>
    </div>
  </footer>
<!------------  SCROLL UP ----------->
<a href="#" class="scrollup" id="scroll-up"> 
  <i class="ri-arrow-up-fill scrollup__icon"></i>
</a>
<script src="../main.js"></script>
<script src="../modal.js"></script>
<script src="../notes-sidebar.js"></script>
</body>
</html>
 
